1305320-66-4 Usage
Molecular structure
Contains a pyrrole ring with two methyl groups at positions 1 and 2, and a carboxylic acid functionality at position 3
Substituents
4-chlorophenyl group at position 5 and 3-iodophenyl group at position 4
Highly substituted compound
Due to the presence of multiple substituents
Potential applications
Potential biological or pharmaceutical applications due to its structural features and potential interactions with other molecules or biological systems. Further studies and research may be required for a better understanding of its properties and potential uses.
Check Digit Verification of cas no
The CAS Registry Mumber 1305320-66-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,0,5,3,2 and 0 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1305320-66:
(9*1)+(8*3)+(7*0)+(6*5)+(5*3)+(4*2)+(3*0)+(2*6)+(1*6)=104
104 % 10 = 4
So 1305320-66-4 is a valid CAS Registry Number.
1305320-66-4Relevant articles and documents
A potent and highly efficacious Bcl-2/Bcl-xL inhibitor
Aguilar, Angelo,Zhou, Haibin,Chen, Jianfang,Liu, Liu,Bai, Longchuan,McEachern, Donna,Yang, Chao-Yie,Meagher, Jennifer,Stuckey, Jeanne,Wang, Shaomeng
, p. 3048 - 3067 (2013/05/22)
Our previously reported Bcl-2/Bcl-xL inhibitor, 4, effectively inhibited tumor growth but failed to achieve complete regression in vivo. We have now performed extensive modifications on its pyrrole core structure, which has culminated in the discovery of 32 (BM-1074). Compound 32 binds to Bcl-2 and Bcl-xL proteins with Ki values of 50 values of 1-2 nM in four small-cell lung cancer cell lines sensitive to potent and specific Bcl-2/Bcl-xL inhibitors. Compound 32 is capable of achieving rapid, complete, and durable tumor regression in vivo at a well-tolerated dose schedule. Compound 32 is the most potent and efficacious Bcl-2/Bcl-xL inhibitor reported to date.